StockData
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. (JSPR) income statement

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.34−1.43 (-12.15%)

Close on Nov 17, 2026Market cap $344.06MP/E –Yield –

Jasper Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-230.3%

Financial strength

Current ratio
1.47
Debt to equity
–
Debt to assets
–
Cash to current liabilities
93.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
243.50
Dividend yield
–

See a number that looks wrong?